Author:
Angajala Anusha,Mothershed Essynce,Davis Melissa B.,Tripathi Shweta,He Qinghua,Bedi Deepa,Dean-Colomb Windy,Yates Clayton
Reference67 articles.
1. Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy;Ongaro;Future Oncol,2018
2. Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis;Jung;J Neurooncol,2018
3. Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site;Lower;Breast Cancer (Dove Med Press),2017
4. Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer;Goncalves;Breast Cancer Res Treat,2017
5. Discordance and Conversion Rates of Progesterone-, Estrogen-, and HER2/neu-Receptor Status in Primary Breast Cancer and Brain Metastasis Mainly Triggered by Hormone Therapy;Timmer;Anticancer Res,2017
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献